Publication #2996

Reference
Drug alert no 17, 18, 19, 20 and 21/2009
Name
Drug alert no 17, 18, 19, 20 and 21: class 2
Categories
Scottish Government Drug Alerts
Organization
Scottish Government Health Directorates
Keywords
NHS SCOTLAND DRUGS SAFETY EFFECTIVENESS DRUG THERAPY PHARMACEUTICAL SERVICES PHARMACEUTICAL INDUSTRY
Description

Attaches drug safety information from the Medicines and Healthcare Products Regulatory Agency (MHRA) for onward transmission.


Drug alert 17: Milpharm Limited are recalling all unexpired stock of Fluoxetine 20mg Capsules product in Karib Kemi Pharm Limited livery only (batches beginning with ‘T’) due to serious Good Manufacturing Practice (GMP) deficiencies.

Drug alert 18: Karib Kemi Pharm Limited are recalling some products (Doxazosin 2mg and 4mg Tablets, Fluoxetine 20mg Capsules) due to serious Good Manufacturing Practice (GMP) deficiencies.

Drug alert 19: LPC Medical (UK) Limited are recalling all unexpired stock of some products (Co-Amilozide 5/50 Tablets, Metformin 500mg Tablets, Metformin 850mg Tablets, Naproxen 250mg Tablets, Naproxen 500mg Tablets) in Karib Kemi Pharm livery only due to serious Good Manufacturing Practice (GMP) deficiencies.

Drug alert 20: Sandoz Limited are recalling some products (Baclofen 10mg Tablets, Fluoxetine 20mg Capsules, Metformin 500mg Tablets, Metformin 850mg Tablets) due to serious Good Manufacturing Practice (GMP) deficiencies.

Drug alert 21: Strandhaven Limited are recalling Amlodipine 5mg and 10mg Tablets due to serious Good Manufacturing Practice (GMP) deficiencies.


Contact Name
Irene Fazakerley
Contact Address
Pharmacy Division, Primary and Community Care Directorate, St Andrew’s House, Regent Road, Edinburgh, EH1 3DG.
Contact Phone

Created
2009-07-01 00:00:00


Click to go back to homepage